Sofradim Production Patents – Insights & Stats

Sofradim Production has a total of 1145 patents globally, out of which 709 have been granted. Of these 1145 patents, more than 45% patents are active. The United States of America is where Sofradim Production has filed the maximum number of patents, followed by Europe (EPO) and Germany. Parallelly, France seems to be the main focused R&D center and also France is the origin country of Sofradim Production.

Sofradim Production is the subpart of Covidien was founded in the year 1999. The Company manufactures and researches medical instruments and apparatuses.

Do read about some of the most popular patents of Sofradim Production which have been covered by us in this article and also you can find Sofradim Production patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sofradim Production patent portfolio.

How many patents does Sofradim Production have?

Sofradim Production has a total of 1145 patents globally. These patents belong to 261 unique patent families. Out of 1145 patents, 517 patents are active.

How Many Patents did Sofradim Production File Every Year?

Sofradim Production Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantSofradim Production Applications FiledSofradim Production Patents Granted
2023117
20221233
20211724
20201943
20192650
20182943
20172758
20163673
20157667
20144056
20136634
201211432
20117517

How many Sofradim Production patents are Alive/Dead?

Worldwide Patents

Sofradim Production Patents Portfolio

How Many Patents did Sofradim Production File in Different Countries?

Sofradim Production Worldwide Patents

Countries in which Sofradim Production Filed Patents

CountryPatents
United States Of America226
Europe155
Germany124
Austria116
Australia110
Canada88
France71
Japan50
China37
Spain36
Hong Kong (S.A.R.)4
Italy4
United Kingdom3
India2
Denmark1
New Zealand1
Brazil1
Ireland1
Portugal1
Turkey1

Where are Research Centers of Sofradim Production Patents Located?

Research Centers of Sofradim Production Patents

10 Best Sofradim Production Patents

US7833234B2 is the most popular patent in the Sofradim Production portfolio. It has received 1124 citations so far from companies like Ethicon, Applied Medical Resources Corporation, and Cilag Gmbh International.

Below is the list of 10 most cited patents of Sofradim Production:

Publication NumberCitation Count
US7833234B21124
US20090004455A11062
US9119898B2769
US8142515B2758
US6547801B1525
US6779701B2298
US6575897B1273
US20030036676A1252
US6596002B2241
US6692506B1222

How many inventions of other companies were rejected due to Sofradim Production patents?

The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Sofradim Production invention. They couldn’t because Sofradim Production had protected those before them.

Examiners at the USPTO referred 59 Sofradim Production patents in 264 rejections (35 USC § 102 or 35 USC § 103 types).

The top citing companies in the Sofradim Production patent portfolio are Boston Scientific Scimed Inc, Coloplast and C R Bard.

List of the Companies whose Patents were rejected citing Sofradim Production –

CompanyNumber of Patent Applications that faced Rejection Citing Sofradim Production PatentsNumber of Rejections (102 & 103)
Boston Scientific Scimed Inc1122
Coloplast A/S89
C R Bard69
Ethicon69
Smith & Nephew514
Edwards Lifesciences322
Midcap Financial Trust23
Innovatus Life Sciences Lending Fund I Lp26
Bvw Holding Ag23
Terumo Kabushiki Kaisha24

Count of 102 and 103 Type Rejections based on Sofradim Production Patents

Top Sofradim Production Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US8933290B211
US6971252B28
US6685629B26
US9242026B25
US7819897B25
US9039979B24
US6695855B14
US7662087B24
US8968762B23
US8808315B23
US9272073B23
US20050125014A13
US8932619B23
US20090036907A13
US9119898B23

What Percentage of Sofradim Production US Patent Applications were Granted?

Sofradim Production (Excluding its subsidiaries) has filed 233 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 174 have been granted leading to a grant rate of 87.8%.

Below are the key stats of Sofradim Production patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Sofradim Production?

Law FirmTotal ApplicationsSuccess Rate
Covidien Lp18888.05%
Oliff Plc2690.48%
Oliff & Berridge7100.00%
Carter Deluca & Farrell Llp366.67%
Peter Deluca333.33%
Kilpatrick Townsend & Stockton Llp2100.00%
Rothwell Figg Ernst & Manbeck Pc2100.00%
Fletcher Yoder10%
Wagenknecht Ip Law Group Pc1100.00%

What are Sofradim Production key innovation segments?

What Technologies are Covered by Sofradim Production?

The chart below distributes patents filed by Sofradim Production in different countries on the basis of the technology protected in patents. It also represents the markets where Sofradim Production thinks it’s important to protect particular technology inventions.

R&D Focus: How has Sofradim Production search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Sofradim Production?

Related Articles

Treetotextile Patents – Insights & Stats (Updated 2024)

Treetotextile has a total of 94 patents globally, out of which 31 have been granted. Of these 94 patents, more than 72% patents are active. Europe (EPO) is where Treetotextile has filed the maximum number of patents, followed by United States of America and India. Parallelly, Sweden seems to be

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.